“Mavacamten and the Reframing of Obstructive Hypertrophic Cardiomyopathy As a Medically Treatable Disease”. 2022. Journal of Heart and Cardiovascular Science 3 (1): 16-21. https://doi.org/10.5281/zenodo.22344598.